Natco Pharma will initially invest US$1 million for a 51 per cent stake in the subsidiary with the remaining 49 per cent to be held by PT Mitra Medis Exim, which is part of the Mitra Jaya Group, as co-promoter. The subsidiary will sell pharmaceuticals in the Indonesian market and is aimed at giving Natco an entry into new geographies for growth and profitability, it said., Natco Pharma will initially invest US$1 million for a 51 per cent stake in the subsidiary with the remaining 49 per cent to be held by PT Mitra Medis Exim, which is part of the Mitra Jaya Group, as co-promoter. The subsidiary will sell pharmaceuticals in the Indonesian market and is aimed at giving Natco an entry into new geographies for growth and profitability, it said., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way